Papers and presented work.
-
01
Heart and Cardiac Substructure Sparing Intensity-Modulated Proton Therapy for Non-Metastatic Breast Cancer
Dr. Nangia and her team report real-world clinical outcomes, toxicity profile, and cardiac dosimetry in non-metastatic breast cancer patients treated with intensity-modulated proton therapy (IMPT).
Read the abstract -
02
Propensity Score-Matched Comparison of Dosimetry and Outcomes of Mucosal-Sparing IMPT and IMRT In South Asian Oral and Oropharyngeal Cancer Patients
The hypothesis is that mucosal-sparing intensity modulated proton therapy (MS-IMPT) improves locoregional control (LRC) and reduces treatment-related adverse effects compared with mucosal-sparing intensity modulated radiation therapy (MS-IMRT) in South Asian patients with oral cavity (OC) and oropharyngeal (OPx) squamous cell carcinoma (SCC). The primary endpoint was 2-year LRC.
Read the abstract -
03
Radiation-Induced Heart Risk in Indian Breast Cancer Patients
Dr. Nangia presents ethnicity-adjusted models to estimate radiation-induced acute coronary risk in Indian breast cancer patients undergoing radiotherapy.
-
04
Proton Therapy Reduces Oral Mucositis in Cancer Patients
Dr. Nangia and her team evaluated IMPT for oral cavity and oropharyngeal cancers, finding lower oral mucositis risk and reduced treatment-related complications.
-
05
Hippocampal Sparing in Radiation Therapy for Oral Cancer
Dr. Nangia and her team show that hippocampal sparing can reduce radiation exposure and predict neurocognitive risks during bucco-alveolar cancer treatment.
-
06
Proton Therapy for Breast Cancer: Cardiac Sparing Benefits
Dr. Nangia and her team report India’s first breast cancer proton therapy experience, showing effective tumor coverage with substantially lower heart and cardiac doses.
-
07
Mouth-Bites in Proton Therapy to Reduce Oral Mucositis
Dr. Nangia and her team found that customized mouth-bites can reduce mucosal radiation exposure and help lower the risk of oral mucositis during proton therapy.
The questions
behind the papers.
The work returns to the same problem: how to keep the dose on the cancer and off everything else — and whether that changes what a patient feels during treatment and years after it.
- Research on IMRT and head and neck cancer treatment
- Cardiac-sparing radiation therapy and advanced radiation techniques
- A patented DIBH device for left-sided breast cancer radiation
- Individualised cardiac risk assessment for the South Asian population
- Teaching and mentoring of postgraduates and registrars
Research informs the plan,
it does not replace it.
Whether any of this applies to your diagnosis depends on the cancer type, its location and stage, and your previous treatment. A consultation is where that is worked out.